ResearcherThe University of SydneyActive in the last 2 years
Josef Gillson
Matched on ORCID iD 0000-0002-0884-3972; OpenAlex author ID A5016719229. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2020: 3 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 7
- Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. Co-author DOI 10.1016/j.addr.2025.115647↗
- Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients. Co-author DOI 10.1111/eci.14341↗
- Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis. Co-author DOI 10.1002/cam4.6407↗
- Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target. Co-author DOI 10.3390/cancers14143528↗
- NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane… First author DOI 10.1016/j.bbagen.2020.129625↗
- PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression. Co-author DOI 10.1016/j.bbagen.2020.129682↗
- Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy? Co-author DOI 10.3390/cancers12051341↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sumit Sahni · 7 shared papers, 2020–2025 · strength 1.23
- Paper Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. DOI 10.1016/j.addr.2025.115647↗
- Paper Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients. DOI 10.1111/eci.14341↗
- Paper Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis. DOI 10.1002/cam4.6407↗
- Jaswinder Singh Samra · 6 shared papers, 2020–2025 · strength 1.10
- Paper Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. DOI 10.1016/j.addr.2025.115647↗
- Paper Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients. DOI 10.1111/eci.14341↗
- Paper Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis. DOI 10.1002/cam4.6407↗
- Anubhav Mittal · 6 shared papers, 2020–2025 · strength 1.10
- Paper Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. DOI 10.1016/j.addr.2025.115647↗
- Paper Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients. DOI 10.1111/eci.14341↗
- Paper Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis. DOI 10.1002/cam4.6407↗
- Anthony James Gill · 4 shared papers, 2020–2025 · strength 0.82
- Paper Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. DOI 10.1016/j.addr.2025.115647↗
- Paper Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients. DOI 10.1111/eci.14341↗
- Paper Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis. DOI 10.1002/cam4.6407↗
- Nick Pavlakis · 4 shared papers, 2020–2025 · strength 0.78
- Paper Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. DOI 10.1016/j.addr.2025.115647↗
- Paper Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients. DOI 10.1111/eci.14341↗
- Paper Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target. DOI 10.3390/cancers14143528↗
- Taymin du Toit‐Thompson · 2 shared papers, 2023–2025 · strength 0.47
- Sooin Byeon · 2 shared papers, 2023–2025 · strength 0.43
- Sarah Maloney · 2 shared papers, 2020–2025 · strength 0.34
- Stephen John Clarke · 1 shared paper, 2025 · strength 0.23
- Angela S. Y. Chou · 1 shared paper, 2025 · strength 0.23
- David Lok Hang Chan · 1 shared paper, 2025 · strength 0.23
- Des Raymond Richardson · 1 shared paper, 2020 · strength 0.13
- Yogambha Ramaswamy · 1 shared paper, 2020 · strength 0.12
- Christopher Bahdah Nahm · 1 shared paper, 2020 · strength 0.11
- Mark P. Molloy · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.